drugset / Trial / NCT04599075

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

NCT04599075 ↗

Phase 4 Completed 70 enrolled Gianna Wilkie
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to perform a randomized trial to investigate if intrapartum insulin delivery mechanisms reduces adverse outcomes associated with type 1 diabetes in pregnancy. The investigators aim to compare subcutaneous insulin pump versus intravenous insulin infusion with regard to the primary outcome of neonatal blood sugar.

Timeline

Start
2021-03-15
Primary completion
2023-05-01
Completion
2023-05-02

Outcome

Missed primary endpoint

paper There was no statistically significant difference in the first neonatal glucose measurement between the 2 groups (50.1±23.4 vs 49.2±22.6; P=.86). PMID 37429432 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic — Intravenous